about
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug...
Read More
4.22
0.36
(9.33%)
44,611
XNAS Volume
High vol. this week
XNAS 29 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Athira Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..